Bio-Rad Laboratories, Inc. Credit Rating

Results 1 - 50 Of 53

Page Of 2 Next

Filter By:

Date	Document Type	Title	Source
09 Sep 2020	Peer Snapshot	Bio-Rad Laboratories, Inc. - June 2020 (LTM): Peer Snapshot	Moody's Investors Service
22 Jun 2020	Credit Opinion	Bio-Rad Laboratories, Inc.: Update to credit analysis - Strong financial profile will help weather coronavirus headwind	Moody's Investors Service
05 Jun 2020	Peer Snapshot	Bio-Rad Laboratories, Inc. - March 2020 (LTM): Peer Snapshot	Moody's Investors Service
15 May 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Bio-Rad Laboratories, Inc.	Moody's Investors Service
24 Mar 2020	Peer Snapshot	Bio-Rad Laboratories, Inc. - December 2019 (LTM): Peer Snapshot	Moody's Investors Service
29 Nov 2019	Peer Snapshot	Bio-Rad Laboratories, Inc. - September 2019 (LTM): Peer Snapshot	Moody's Investors Service
11 Sep 2019	Peer Snapshot	Bio-Rad Laboratories, Inc. - June 2019 (LTM): Peer Snapshot	Moody's Investors Service
01 Jul 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Bio-Rad Laboratories, Inc.	Moody's Investors Service
28 Jun 2019	Credit Opinion	Bio-Rad Laboratories, Inc.: Update to credit analysis following upgrade to Baa2	Moody's Investors Service
27 Jun 2019	Rating Action	Moody's upgrades Bio-Rad to Baa2, outlook is stable	Moody's Investors Service
19 Jun 2019	Peer Snapshot	Bio-Rad Laboratories, Inc. - March 2019 (LTM): Peer Snapshot	Moody's Investors Service
22 Apr 2019	Peer Snapshot	Bio-Rad Laboratories, Inc. - December 2018 (LTM): Peer Snapshot	Moody's Investors Service
12 Dec 2018	Peer Snapshot	Bio-Rad Laboratories, Inc. - September 2018 (LTM): Peer Snapshot	Moody's Investors Service
19 Sep 2018	Peer Snapshot	Bio-Rad Laboratories, Inc. - June 2018 (LTM): Peer Snapshot	Moody's Investors Service
03 Jul 2018	Credit Opinion	Bio-Rad Laboratories, Inc.: Update to credit analysis following change in outlook to positive	Moody's Investors Service
03 Jul 2018	Rating Action	Moody's affirms Bio-Rad's Baa3 senior unsecured rating; changes outlook to positive from stable	Moody's Investors Service
18 Jun 2018	Peer Snapshot	Bio-Rad Laboratories, Inc. - March 2018 (LTM): Peer Snapshot	Moody's Investors Service
23 May 2018	Peer Snapshot	Bio-Rad Laboratories, Inc. - December 2017 (LTM): Peer Snapshot	Moody's Investors Service
04 Mar 2018	Announcement	Moody's: Bio-Rad's delayed 10-K filing is credit negative	Moody's Investors Service
02 Mar 2018	Issuer Comment	Bio-Rad Laboratories, Inc.: Delayed 10-K filing is credit negative	Moody's Investors Service
20 Dec 2017	Peer Snapshot	Bio-Rad Laboratories, Inc. - September 2017 (LTM): Peer Snapshot	Moody's Investors Service
12 Sep 2017	Peer Snapshot	Bio-Rad Laboratories, Inc. - June 2017 (LTM): Peer Snapshot	Moody's Investors Service
07 Jul 2017	Credit Opinion	Bio-Rad Laboratories, Inc.: Update to Discussion of Key Credit Factors	Moody's Investors Service
07 Jun 2017	Peer Snapshot	Bio-Rad Laboratories, Inc. - March 2017 (LTM): Peer Snapshot	Moody's Investors Service
31 Mar 2017	Peer Snapshot	Bio-Rad Laboratories, Inc. - December 2016 (LTM): Peer Snapshot	Moody's Investors Service
14 Nov 2016	Peer Snapshot	Bio-Rad Laboratories, Inc. - Q3 2016: Peer Snapshot	Moody's Investors Service
08 Jul 2016	Credit Opinion	Bio-Rad Laboratories, Inc.: Update to Discussion of Key Credit Factors	Moody's Investors Service
09 Jul 2015	Credit Opinion	Bio-Rad Laboratories, Inc.	Moody's Investors Service
17 Jul 2014	Rating Action	Moody's upgrades Bio-Rad to Baa3 from Ba1; outlook stable	Moody's Investors Service
15 Nov 2013	LGD Assessment	Bio-Rad Laboratories, Inc.	Moody's Investors Service
15 Nov 2013	Rating Action	Moody's affirms Bio-Rad's Ba1	Moody's Investors Service
18 Apr 2012	Analysis	Bio-Rad's Metrics Are Stronger, But PerkinElmer Is More Diverse	Moody's Investors Service
05 Apr 2012	Announcement	Moody's affirms Bio-Rad's Ba1 CFR; changes outlook to positive	Moody's Investors Service
08 Feb 2011	Special Comment	Overlooked Life Science Sector Has Strong Growth Prospects	Moody's Investors Service
07 Dec 2010	LGD Assessment	Bio-Rad Laboratories, Inc.	Moody's Investors Service
06 Dec 2010	Rating Action	Moody's affirms Bio-Rad's Ba1 CFR; assigns Ba1 to new notes	Moody's Investors Service
07 Jan 2010	LGD Assessment	Bio-Rad Laboratories, Inc.	Moody's Investors Service
06 Jan 2010	Rating Action	Moody's upgrades Bio-Rad to Ba1; outlook stable	Moody's Investors Service
27 Jul 2009	Covenant Quality Assessment	Bio-Rad Laboratories, Inc. - $200 million 6.125% Senior Subordinated Notes due 2014	Moody's Investors Service
27 Jul 2009	Covenant Quality Assessment	Bio-Rad Laboratories, Inc. - $225 million 7.50% Senior Subordinated Notes due 2013	Moody's Investors Service
27 Jul 2009	Covenant Quality Assessment	Bio-Rad Laboratories, Inc. - $300 million 8% Senior Subordinated Notes due 2016	Moody's Investors Service
09 Jul 2009	LGD Assessment	Bio-Rad Laboratories, Inc.	Moody's Investors Service
21 May 2009	LGD Assessment	Bio-Rad Laboratories, Inc.	Moody's Investors Service
19 May 2009	Rating Action	Moody's rates Bio-Rad's proposed sub notes Ba3	Moody's Investors Service
18 May 2009	Rating Action	Moody's changes Bio-Rad's outlook to positive	Moody's Investors Service
02 Oct 2006	LGD Assessment	Bio-Rad Laboratories, Inc.	Moody's Investors Service
28 Sep 2006	Rating Action	Moody's changes ratings on 16 medical device companies under LGD rating methodology	Moody's Investors Service
13 Dec 2004	Rating Action	MOODY'S INVESTORS SERVICE ASSIGNS A RATING OF Ba3 TO BIO RAD LABORATORIES' $200 MILLION SENIOR SUBORDINATED NOTES, DUE 2014, AND AFFIRMS EXISTING RATINGS	Moody's Investors Service
06 Aug 2003	Opinion Update	Bio-Rad Laboratories, Inc.	Moody's Investors Service
31 Jul 2003	Rating Action	MOODY'S ASSIGNS A Ba3 TO BIO-RAD LABORATORIES, INC.'S ("BIO-RAD'S") $200 MILLION SR. UNSEC. SUB. NOTES AND UPGRADES ITS SENIOR IMPLIED RATING TO Ba2 FROM Ba3; OUTLOOK IS CHANGED TO POSITIVE	Moody's Investors Service

Results 1 - 50 Of 53

Page Of 2 Next

Registered User

Not Registered Yet?